coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Stockport East And South PCN, Stockport (LAD) · Health Inequalities Profile

    PCN U64597 · NHS Greater Manchester Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    59,946

    Registered population

    56.1% aged 18–64

    26.0%

    Aged 65+

    ICB 14.9% · England 17.9%

    3.6%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~1,979

    Core20 residents (est.)

    Resident basis; registered basis ~1,961 · see page 3

    11,325

    Hypertension register

    +6.38% in 3 yrs · England +5.60%

    529

    SMI register

    15.8% of Stockport (LAD)'s

    1,352

    COPD register

    Reviews -0.32% in 3 yrs

    Forecast to 2030

    12,971

    Hypertension patients, 2030

    +1,646 on today

    68.3%

    QRISK ≥20% on statins, 2030

    +3.08pp over 3 yrs

    6.1%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    17.9%
    Deprivation concentrates at Archwood Medical Practice.

    Archwood Medical Practice has a 17.9% Core20 share (1,369 estimated patients), which may warrant targeted outreach if local register audits confirm unmet need.

    61.6%
    Lipid therapy trails England at higher unit cost.

    Lipid therapy in QRISK >= 20% (61.6% vs England 63.6%) and CKD (68.0% vs 70.3%) trails England, while unit cost is £2.10 vs £1.86.

    78.6%
    Strong blood pressure and chronic review baselines.

    Hypertension control (78.6% vs England 70.3%), COPD reviews (86.6% vs 76.4%) and heart failure reviews (87.2% vs 78.5%) exceed England, though 18 trends trail.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over reach 26.0%, well above borough and national levels

    Across eight practices, the PCN registers 59,946 patients: 26.0% (15,578) are aged 65+, against 19.7% in Stockport (LAD), 14.9% in NHS Greater Manchester Integrated Care Board, and 17.9% in England. Working-age adults (18-64) comprise 56.1% (33,645) and children (0-17) 17.9% (10,723). ONS projected list growth to 2030 is 0.6% (LAD 1.1%, ICB 1.6%, England 2.3%; unverified method). Registered lists differ from resident Census data, where Gypsy or Irish Traveller (0.0%) and Roma (0.0%) match LAD (0.0%, 0.0%) and trail the ICB (0.1%, 0.1%) and England (0.1%, 0.2%).

    Age profile

    0–1717.9%
    18–6456.1%
    65+26.0%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Stockport (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Stockport LA)2,0722,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Stockport LA)9191,0219552024/25
    Falls deaths, all ages, per 100,000 (Stockport LA)23.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 3.6% overall and concentrates sharply in Archwood Medical Practice

    Stockport East and South PCN averages IMD decile 7.1, above Stockport (LAD) (6.4), NHS Greater Manchester Integrated Care Board (4.5) and England (5.5). Core20 prevalence is 3.6%, below Stockport (LAD) (16.1%), the ICB (40.7%) and England (21.0%). Practice shares weight to 3.3% versus 1,979 estimated Core20 residents. Deprivation concentrates heavily: Archwood Medical Practice records 17.89% share (1,369 estimated patients), Chadsfield Medical Practice 5.26% (344), and Marple Cottage Surgery 2.16% (248), while five practices record 0.0%. Prioritise targeted outreach and preventive checks on practices carrying the PCN's Core20 caseload.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Archwood Medical17.9% · 1,369 patients
    Chadsfield5.3% · 344 patients
    Marple Cottage2.2% · 248 patients
    Marple Bridge0.0% · 0 patients
    Beech House0.0% · 0 patients
    Marple Medical0.0% · 0 patients
    Springfield0.0% · 0 patients
    High Lane0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    529

    SMI register

    0.88% recorded prevalence

    291

    Learning disability register

    0.48% recorded prevalence

    27

    Care homes, 977 beds

    In the PCN catchment

    9.5%

    Provide unpaid care

    Stockport (LAD), Census 2021

    Recorded severe mental illness prevalence is 0.9% (529 patients), below Stockport (LAD) (1.0%), NHS Greater Manchester Integrated Care Board (1.1%), and England (1.0%). Learning disability prevalence is 0.5% (291 patients) versus 0.6% across Stockport (LAD), the ICB, and England. Catchment care homes total 27 with 977 beds. Lower recorded prevalence across comparators may reflect diagnostic coding patterns, which register audits would test.

    Severe mental illness: physical health checks

    Physical checks for severe mental illness exceed England, including blood pressure at 89.5% (England 83.4%), alcohol recording at 89.9% (England 81.8%), and BMI at 88.8% (England 82.1%). Over 2023 to 2025, blood pressure recording rose +1.0 pp (England +4.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    11,325

    Hypertension register

    +6.38%

    Register growth, 3 yrs

    Stockport (LAD) +4.99% · England +5.60%

    +0.60pp

    BP control, under 80

    ≤140/90 · −0.83pp aged 80+

    +1,646

    More patients by 2030

    Forecast 12,971 (21.30%)

    Hypertension case-finding and control

    The PCN records 11,325 patients on its hypertension register, representing a prevalence of 18.8%, above Stockport (16.2%), NHS Greater Manchester ICB (14.4%), and England (15.2%). Blood pressure control remains strong: 78.6% of hypertensive patients are treated to target, compared with 73.6% in Stockport, 71.4% in the ICB, and 70.3% in England. Among hypertensive patients aged 80 and over, 86.8% had a blood pressure reading <= 150/90 mmHg (England 81.2%), though this fell 0.9% over 2023 to 2025 (England +2.2%).

    Lipids and statins

    Lipid therapy trails England in QRISK ≥ 20% (61.6% vs 63.6%), CKD (68.0% vs 70.3%), and diabetes without CVD (72.3% vs 73.2%) or with CVD (81.9% vs 84.4%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026139,275£2.10£1.94£1.86£292,478
    Cardiovascular (all), 2025194,754£3.81£3.15£3.33£742,013

    For lipid-regulating drugs, the PCN prescribed 139,275 items at £2.10 per item, above Stockport (£1.99), NHS Greater Manchester ICB (£1.94), and England (£1.86). This represents £33,426 more than at England's unit cost, across 139,275 items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −3.63%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.88%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.4% (4,226 patients; England 6.6%) and COPD prevalence is 2.2% (1,352 patients; England 1.9%). Recorded reviews exceed England in COPD (86.6% vs 76.4%) and asthma (70.2% vs 65.7%). Over 2023 to 2025, asthma reviews fell 3.6% (England +4.4%), leaving about 1,300 unreviewed patients (modelled gap 1,261). Asthma management prescribing for ages 5-19 reaches 1,720 per 1,000 (England 1,488).

    Cancer register and children's immunisation

    Cancer register prevalence is 5.3% (3,167 patients; England 3.8%). In Q1 2025/26, childhood 6-in-1 coverage is 96.9% and age-5 MMR1 is 99.3%, both above the 95.0% target. However, age-5 MMR2 is 94.8% (4.5 pp below MMR1) and 4-in-1 pre-school booster is 92.5%, trailing the 95.0% target by 0.2 pp and 2.5 pp respectively.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.9%

    England 91.0%

    6-in-1 complete primary course at 24 months95.1%

    England 92.2%

    MMR dose 1 at 24 months95.1%

    England 88.3%

    MMR dose 2 at age 594.8%

    England 82.8%

    4-in-1 pre-school booster at age 592.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2 (England 55.3%), 19.4 pp below the 75.0% national ambition (2,268.2 extra cases needed), gaining +3.1 pp since 2013 (52.4%). Known-stage coverage was 70.8% (11,679 of 16,492 cases; England 67.0%). Site staging varies: breast reached 82.5%, bowel 46.3%, and lung 40.4%. At PCN level, cancer prevalence is 5.3% (3,167 patients) with 3-year register growth of +8.0% (England +9.0%), trailing at Beech House Medical Pract (+1.6%) and Archwood Medical Practice (+3.6%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Stockport NHS Foundation Trust, 28-day faster diagnosis was 83.2% (8.2 pp above the 75.0% standard) and 31-day combined treatment was 97.4% (1.4 pp above the 96.0% standard), but 62-day referral to treatment was 74.7% (10.3 pp below the 85.0% standard). Across NHS Greater Manchester Integrated Care Board, 28-day faster diagnosis was 79.5% (4.5 pp above standard) and 31-day treatment was 96.5% (0.5 pp above standard), while 62-day referral to treatment was 75.7% (9.3 pp below standard). Slower 62-day pathways reflect wider system operational pressure rather than PCN-level performance.

    Pathways within standard (%)StockportTameside and Glossop Integrated CareManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)83.2182.4880.0679.5379.32
    31-day treatment (96%)97.3996.2592.5496.4992.50
    62-day referral to treatment (85%)74.6776.7772.8575.7371.16
    Diagnostic waits over 6 weeks (%)StockportTameside and Glossop Integrated CareManchesterEngland
    MRI1.410.0011.6821.40
    CT2.930.1814.669.92
    Echocardiography17.460.004.9128.48
    Colonoscopy5.531.514.5130.83
    Gastroscopy5.315.4529.3529.02
    All 15 DM01 tests14.080.808.9823.14
    Community services activityStockport residentsGreater Manchester ICB
    Care contacts57,085573,310
    Referrals10,69094,470
    Patients with a contact16,950183,535

    Community services (residents of Stockport), Jun 2026 (provisional). In Stockport borough, older adults account for the substantial majority of community health activity: 60.6% of all recorded community service contacts (34,585 of 57,085 contacts) were with residents aged 65 and over (provisional Jun 2026 data). Because community activity is captured only at local authority resident level, it reflects broader system utilisation rather than PCN-specific delivery, consistent with supporting an ageing population.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone contact ease spans 29.4 pp across practices alongside wide vaccination achievement variation

    In 2025/26, QOF overall achievement ranged from 93.2% at Archwood Medical Practice to 100.0% at Marple Bridge Surgery and Marple Cottage Surgery (England 92.5%). However, vaccination and immunisation achievement showed a 56.5 pp spread, spanning 43.5% at Archwood Medical Practice to 100.0% at Marple Bridge Surgery, suggesting immunisation delivery varies considerably between member practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    High Lane1150.098.3%83.1%98.7%
    Marple Bridge1080.094.5%71.2%96.2%
    Beech House990.071.6%68.4%91.9%
    Marple Cottage972.293.5%82.4%91.0%
    Marple Medical1120.088.2%79.0%90.1%
    Springfield1370.088.6%83.7%89.9%
    Chadsfield1085.368.9%81.9%89.6%
    Archwood Medical10717.987.6%84.1%88.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNStockport (LAD)AssetPCNStockport (LAD)
    Care homes (catchment)27 (977 beds)n/aSchools (catchment)71n/a
    Children's centresno data2Places of worship43135
    Libraries512Food banks (VCS)n/a1
    Primary schools (LA maintained)1461Primary academies1123
    Special schools14

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Across the 4,226-patient asthma register (7.4% prevalence), the review rate is 70.2% (England 65.7%), falling 3.6% over 2023 to 2025 (England +4.4%), leaving 1,261 unreviewed patients (about 1,300). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Lipid-modifying therapy and prescribing review

    Lipid therapy trails England in QRISK >= 20% (61.6% vs 63.6%), CKD (68.0% vs 70.3%) and diabetes (72.3% vs 73.2%; with CVD 81.9% vs 84.4%); unit cost is £2.10 vs England £1.86 (£33,426 more across 139,275 items). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Learning disability register validation

    Recorded learning disability prevalence is 0.5% (291 patients) across the 59,946 list, below 0.6% in Stockport (LAD), NHS Greater Manchester Integrated Care Board and England, giving a modelled gap of +44 to +61 patients. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register review (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check audit (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older hypertensive patient review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register review (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephony and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Lipid-modifying therapy and prescribing review (p12)Hypertension register · Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15